An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Clinical trial NCT02431260 · TERMINATED
Trial details
- NCT number
- NCT02431260
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-14
- Primary completion
- 2018-01-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.